Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/3/26 21:32 | 5/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Sloan Sheldon | MA | O | Chief Me | 3 | S.d | -6,624 | 70.00 | 0 | -95 | -100 | 0 | D | ||||||||||||||
6/3/26 21:31 | 5/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | 8 | S | -5,937 | 39.58 | 0 | -150 | 702 | D | |||||||||||||||
6/3/26 21:30 | 5/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | 5 | S.d | -2,196 | 45.35 | 0 | -48 | 98 | D | |||||||||||||||
5/8/26 21:31 | 5/8/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Henderson Michael Thomas | MA | D | 1 | S | -5,952 | 74.40 | 0 | -80 | 89 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |